NIRA: A New Inter-Domain Routing Architecture von Yang, X.., Clark, D.., Berger, A.W.

Volltext

Fast portscan detection using sequential hypothesis testing von Jaeyeon Jung, Paxson, V., Berger, A.W., Balakrishnan, H.

Volltext

Dimensioning bandwidth for elastic traffic in high-speed data networks von Berger, A.W., Kogan, Y.

Volltext

2363 Sorafenib plus Doxorubicin versus Sorafenib alone for advanced hepatocellular carcinoma (Soradox trial): final results of a prospective, randomized, open-label, multicenter ph... von Ettrich, T, Perkofer, L, Berger, A.W, Güthle, M, Behl, S, Zipprich, A, Wörns, M.A, Waldschmidt, D.T, Belle, S, Michl, P, Seufferlein, T, Dollinger, M.M

Volltext

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group von Seufferlein, T., Uhl, W., Kornmann, M., Algül, H., Friess, H., König, A., Ghadimi, M., Gallmeier, E., Bartsch, D.K., Lutz, M.P., Metzger, R., Wille, K., Gerdes, B., Schimanski, C.C., Graupe, F., Kunzmann, V., Klein, I., Geissler, M., Staib, L., Waldschmidt, D., Bruns, C., Wittel, U., Fichtner-Feigl, S., Daum, S., Hinke, A., Blome, L., Tannapfel, A., Kleger, A., Berger, A.W., Kestler, A.M.R., Schuhbaur, J.S., Perkhofer, L., Tempero, M., Reinacher-Schick, A.C., Ettrich, T.J.

Volltext

NIFE-trial: Liposomal irinotecan (nal-IRI) plus 5-fluorouracil (5-FU) and leucovorin (LV) or gemcitabine plus cisplatin in advanced biliary-tract cancer: An open label, randomized,... von Ettrich, T.J., Perkhofer, L., Berger, A.W., Seufferlein, T.

Volltext

581P - A biomarker combination indicating resistance to FOLFOX plus bevacizumab in metastatic colorectal cancer: Results of phase I of the PERMAD trial von Seufferlein, T., Ettrich, T.J., Stein, A., Arnold, D., Prager, G., Kasper, S., Niedermeier, M., Mueller, L., Kubicka, S., König, A.-O., Büchner-Steudel, P., Wille, K., Kestler, A., Hann, A., Perkhofer, L., Berger, A.W., Lausser, L., Kestler, H.

Volltext

A biomarker combination indicating resistance to FOLFOX plus bevacizumab in metastatic colorectal cancer: Results of phase I of the PERMAD trial von Seufferlein, T., Ettrich, T.J., Stein, A., Arnold, D., Prager, G., Kasper, S., Niedermeier, M., Mueller, L., Kubicka, S., König, A.-O., Büchner-Steudel, P., Wille, K., Kestler, A., Hann, A., Perkhofer, L., Berger, A.W., Lausser, L., Kestler, H.

Volltext

A composite liquid biomarker for non-invasive diagnosis of resectable pancreatic ductal adenocarcinoma von Berger, A.W., Ettrich, T.J., Schwerdel, D., Reinacher-Schick, A., Algül, H., König, A.-O., Gallmeier, E., Wille, K., Daum, S., Geissler, M., Tannapfel, A., Uhl, W., Seufferlein, T.

Volltext

Genotyping of circulating tumor DNA in biliary tract cancer reveals diagnostic and prognostic information von Ettrich, T.J., Schwerdel, D., Dolnik, A., Beuter, F., Blätte, T., Schmidt, S.A., Stanescu-Siegmund, N., Steinacker, J., Marienfeld, R., Kleger, A., Bullinger, L., Seufferlein, T., Berger, A.W.

Volltext

TRICC-C: Nintedanib vs. placebo in patients receiving mFOLFOX6 for metastatic, chemorefractory colorectal cancer: Final results from the randomized phase II trial of the AIO von Ettrich, T J, Berger, A W, Decker, T, Hofheinz, R D, Heinemann, V, Hoffmann, T, Hebart, H F, Herrmann, T, Hannig, C-V, Büchner-Steudel, P, Bartholomäus, H, Güthle, M, Perkhofer, L, Seufferlein, T

Volltext

A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial von Seufferlein, T, Lausser, L, Stein, A, Prager, G, Kasper, S, Niedermeier, M, Müller, L, Kubicka, S, König, A-O, Büchner-Steudel, P, Wille, K, Perkhofer, L, Hann, A, Berger, A W, Arnold, D, Kestler, H, Ettrich, T J

Volltext

Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study von Kruger, S.F., Lohneis, A., Abendroth, A., Berger, A.W., Ettrich, T.J., Waidmann, O., Kapp, M., Steiner, B., Kumbrink, J., Reischer, A., Haas, M., Westphalen, C.B., Zhang, D., Miller-Phillips, L., Burger, P.J., Kobold, S., Werner, J., Subklewe, M., von Bergwelt-Baildon, M., Kunzmann, V., Seufferlein, T., Siveke, J.T., Sinn, M., Heinemann, V., Ormanns, S., Boeck, S.

Volltext

Performance analysis of a rate-control throttle where tokens and jobs queue von Berger, A.W.

Volltext

Real time pricing to assist in load frequency control von Berger, A.W., Schweppe, F.C.

Volltext

Effective bandwidths with priorities von Berger, A.W., Whitt, W.

Volltext

Traffic descriptors for VBR video teleconferencing over ATM networks von Reibman, A.R., Berger, A.W.

Volltext

Supplementary Material for: Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study von J.J., Meyer, J., Dreyhaupt, D., Schwerdel, T.J., Ettrich, J., Backhus, M.M., Dollinger, T., Seufferlein, A.W., Berger

Volltext bestellen

Supplementary Material for: Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study von Meyer, J.J., Dreyhaupt, J., Schwerdel, D., Ettrich, T.J., Backhus, J., Dollinger, M.M., Seufferlein, T., Berger, A.W.

Volltext bestellen

Comparison of call gapping and percent blocking for overload control in distributed switching systems and telecommunications networks von Berger, A.W.

Volltext